| scholarly article | Q13442814 |
| P2093 | author name string | Ke Yuan | |
| Carlos Medina | |||
| Paul L Bollyky | |||
| Nadine Nagy | |||
| Swathi Balaji | |||
| Gernot Kaber | |||
| Sundeep Keswani | |||
| Michael J Kratochvil | |||
| Emily Steen | |||
| Ananya Chakraborty | |||
| Vinicio A De Jesus Perez | |||
| Elya A Shamskhou | |||
| Mark E Orcholski | |||
| Abinaya Nathan | |||
| Ben Danielson | |||
| Max Gao | |||
| P2860 | cites work | Hyaluronidase expression and activity is regulated by pro-inflammatory cytokines in human airway epithelial cells | Q24317310 |
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib | Q26771647 | ||
| Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family | Q26801150 | ||
| Fibroblasts in fibrosis: novel roles and mediators | Q26998508 | ||
| Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system | Q54379823 | ||
| Transforming growth factor-beta: biological function and chemical structure | Q61688125 | ||
| Self-assembled dextrin nanogel as protein carrier: Controlled release and biological activity of IL-10 | Q61941056 | ||
| Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1 | Q73441963 | ||
| Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10 | Q73711425 | ||
| Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease | Q73746069 | ||
| Outstaying their Welcome: The Persistent Myofibroblast in IPF | Q85769868 | ||
| Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease | Q86985214 | ||
| Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients | Q87450564 | ||
| Lung transplantation in idiopathic pulmonary fibrosis | Q88284754 | ||
| Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer | Q88814078 | ||
| Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta | Q93534412 | ||
| Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature | Q27004290 | ||
| Interleukin-10 | Q28263225 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts | Q28539207 | ||
| Transcriptional control by the TGF-beta/Smad signaling system | Q29618985 | ||
| TGF-beta signaling from receptors to the nucleus | Q30829255 | ||
| Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10 | Q33719352 | ||
| Cold Chain-Free Storable Hydrogel for Infant-Friendly Oral Delivery of Amoxicillin for the Treatment of Pneumococcal Pneumonia | Q33781396 | ||
| Development of fibrin derivatives for controlled release of heparin-binding growth factors | Q33892025 | ||
| Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. | Q35102315 | ||
| Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis | Q35558781 | ||
| Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta | Q35763762 | ||
| Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis | Q35774175 | ||
| Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts | Q35824711 | ||
| Current and novel drug therapies for idiopathic pulmonary fibrosis | Q36294959 | ||
| Simple method of estimating severity of pulmonary fibrosis on a numerical scale | Q36451354 | ||
| Hyaluronan in tissue injury and repair | Q36824173 | ||
| HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM. | Q36964047 | ||
| Immunotherapy with injectable hydrogels to treat obstructive nephropathy | Q37591586 | ||
| The treatment of idiopathic pulmonary fibrosis. | Q37621515 | ||
| Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling | Q37629464 | ||
| Reduction of intraoperative air leaks with Progel in pulmonary resection: a comprehensive review | Q38099471 | ||
| Incorporation of heparin into biomaterials | Q38135949 | ||
| Diagnosis and classification of idiopathic pulmonary fibrosis | Q38178458 | ||
| Cellular interactions in the pathogenesis of interstitial lung diseases | Q38366253 | ||
| Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player? | Q38638213 | ||
| Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities | Q39306543 | ||
| In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. | Q40261230 | ||
| Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo | Q40883930 | ||
| Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice | Q40998851 | ||
| Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis | Q41095169 | ||
| Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts | Q41955517 | ||
| Targeting Inflammatory Cytokines and Extracellular Matrix Composition to Promote Wound Regeneration | Q42355541 | ||
| CD44 positive macrophages take up hyaluronan during lung development | Q42812166 | ||
| Time course of bleomycin-induced lung fibrosis. | Q44181987 | ||
| Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles | Q45193717 | ||
| Novel approach with intratracheal administration of microgelatin hydrogel microspheres incorporating basic fibroblast growth factor for rescue of rats with monocrotaline-induced pulmonary hypertension | Q46233020 | ||
| IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. | Q50649901 | ||
| Regulation of interleukin-10 gene expression: possible mechanisms accounting for its upregulation and for maturational differences in its expression by blood mononuclear cells. | Q52194403 | ||
| Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis. | Q52937788 | ||
| P921 | main subject | pulmonary fibrosis | Q32446 |
| hydrogel | Q898925 | ||
| P304 | page(s) | 52-62 | |
| P577 | publication date | 2019-02-22 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice | |
| P478 | volume | 203 |
| Q89966619 | The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis | cites work | P2860 |
Search more.